Skip to main content


You are here

UM Ventures News

OmniSpeech OmniClear™ Speech Extraction and Noise Suppression Technology Released in Alcatel's MOVE TIME Smart Watch

OmniClearTM technology is now included in the latest Alcatel MOVE TIME smart watch.

Five Startups on Fast Track to Grow Their Businesses Courtesy of Baltimore’s Big Names in Fitness and Health Care

M-1 Ventures’ accelerator program to provide emerging businesses funding and mentorship from experts at Johns Hopkins and Plank Industries.

Gliknik Announces Dosing of First Patient in Phase 2 Trial Targeting Prevention of Recurrence of High-Risk Oral Cavity Cancer

Gliknik Inc. today announced that clinicians have enrolled and dosed the first of 80 patients in the company’s phase 2 clinical trial.

Global University Venturing - USM Gains Momentum with Wise

Read an article about USM gaining momentum via Global University Venturing. Baltimore: David Wise Named Director of University System of Maryland’s Early-Stage Investment Fund

The University System of Maryland was recently named a leader for its early stage investment fund that is seeking to back early-stage startups.

IonQ Raises $20M Series B Round Led by NEA, GV to Advance Quantum Computing for Commercial Applications

IonQ today announced completion of a $20 million series B round led by New Enterprise Associates (NEA) and GV (formerly Google Ventures).

USM Names David W. Wise Director of Maryland Momentum Fund

The University System of Maryland (USM) has named business innovator David W. Wise, MALD, as director of the Maryland Momentum Fund (MMF).

Baltimore Business Journal: University of Maryland is Salvaging Tech, Turning it into Fast-Growing Startups

The UM Ventures team decided to help take an active role in young companies, to move them toward commercialization.

Baltimore Sun: University of Maryland School of Medicine Startup Acquired

Living Pharma Inc., a cancer treatment startup out of the University of Maryland School of Medicine, has been acquired by Lentigen Technology.

Lentigen Technology Inc., a Miltenyi Biotec Company, Acquires University of Maryland, Baltimore CAR-T Cell Start-Up, Living Pharma, Inc.

Lentigen Technology Inc., a subsidiary of Miltenyi Biotec GmbH, announced today its acquisition of immunotherapy start-up Living Pharma, Inc.